Share this post on:

Product Name :
Metformin Hydrochloride/Ertugliflozin

Search keywords :
Ertugliflozin L-pyroglutamic acid

drugId :
null

Target Vo:
Protein kinase AMP-activated non-catalytic subunit beta 1

Target Vo Short Name :
PRKAB1

Moa_Name:
Sodium/glucose cotransporter 2 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2017

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Merck & Co Inc

Active Indication_Name:
Diabetes Mellitus, Type 2

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-PKA RII alpha (Ser99) Rabbit pAb supplier
Polatuzumab ADC Antibody
HSF1 Antibody (YA896): HSF1 Antibody (YA896) is an unconjugated, approximately 57-80 kDa, rabbit-derived, anti-HSF1 (YA896) monoclonal antibody. HSF1 Antibody (YA896) can be used for: WB, IHC-P, ICC/IF, IP, FC expriments in human background without labeling.

Share this post on:

Author: Interleukin Related